Clinical Trial Update: Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient [NA]

View source ↗

Summary

This clinical trial update notes anemia correction and Fibroblast Growth Factor 23 level assessment in chronic kidney disease and renal transplant patients, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease
• Chronic Kidney Disease
• Endothelial Dysfunction
• Left Ventricular Hypertrophy

Snippet

Sponsor: Omnia Mohammed Hashem | Conditions: Anemia of Chronic Kidney Disease, Endothelial Dysfunction | NA | Status: SUSPENDED